Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

24.52
+0.29001.20%
Post-market: 24.520.00000.00%19:04 EDT
Volume:538.97K
Turnover:13.31M
Market Cap:1.21B
PE:-7.68
High:25.49
Open:23.98
Low:23.86
Close:24.23
52wk High:28.00
52wk Low:6.57
Shares:49.22M
Float Shares:33.00M
Volume Ratio:0.70
T/O Rate:1.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1931
EPS(LYR):-3.1931
ROE:-89.18%
ROA:-33.59%
PB:0.42
PE(LYR):-7.68

Loading ...

Apr 28, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 22, 2026

Major Issues Report

Form 8-K - Current report
Apr 03, 2026

Major Issues Report

Form 8-K - Current report
Mar 06, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 06, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2026

Major Issues Report

Form 8-K - Current report
Jan 05, 2026

Major Issues Report

Form 8-K - Current report
Dec 23, 2025

Correspondence

Form CORRESP - Correspondence
Dec 22, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 15, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2025

Major Issues Report

Form 8-K - Current report
Oct 07, 2025

Major Issues Report

Form 8-K - Current report
Sep 09, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2025

Major Issues Report

Form 8-K - Current report
Jul 01, 2025

Major Issues Report

Form 8-K - Current report
Jun 30, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities